Cancer Research UK logo.
SearchDonate
  • Search

A trial of cabazitaxel for transitional cell bladder cancer that has spread (CAB B1)

Overview

Cancer types:

Bladder cancer, Kidney cancer, Transitional cell cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at a chemotherapy drug called cabazitaxel for transitional cell cancer of the bladder or urinary system. It is for people who have cancer that has spread and has got worse despite having chemotherapy with a .

Recruitment start: 4 January 2013

Recruitment end: 31 October 2016

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Anjali Zarkar

Supported by

Sanofi

University Hospital Birmingham NHS Foundation Trust

University of Warwick

Last reviewed: 01 Nov 2016

CRUK internal database number: 10721

Help and support